HIV News and Research

RSS

Eligibility criteria lack clarity, justification for excluding people with disabilities from clinical trials

Despite constituting the largest minority group in the U.S. and expressing interest in participating in clinical trials, people with disabilities remain excluded.

3 Oct 2022

French study reports growing evidence of sexual activity-linked transmission of monkeypox

In a new study, researchers described patients with monkeypox virus (MPXV) infection.

3 Oct 2022

Obscure family of viruses already endemic in African monkeys "poised for spillover" to humans

An obscure family of viruses, already endemic in wild African primates and known to cause fatal Ebola-like symptoms in some monkeys, is "poised for spillover" to humans, according to new University of Colorado Boulder research published online Sept. 30 in the journal Cell.

30 Sep 2022

Gut microbiome could contribute to a person's risk for HIV infection, research suggests

New UCLA-led research suggests certain gut bacteria -- including one that is essential for a healthy gut microbiome – differ between people who go on to acquire HIV infection compared to those who have not become infected.

30 Sep 2022

Effectiveness of anti-SARS-CoV-2 immunoadhesin against omicron and other emerging variants

A new study demonstrated the efficacy of a newly engineered angiotensin-converting enzyme 2 (ACE2) based immunoadhesin against Omicron and other SARS-CoV-2 VOCs.

30 Sep 2022

Gut microbiome likely to contribute to HIV infection

30 Sep 2022

Duration of infectiousness, predictors of ongoing individual infectiousness, and diagnostic tests for acute SARS-CoV-2 infection

Researchers explored SARS-CoV-2 variants of concern/interest (VOC/VOI) kinetics and variations among non-hospitalized acute COVID-19 patients.

29 Sep 2022

Natural product SSP derived from a Chinese herb may have broad antiviral activities against respiratory viral infections

A research team comprised of members of the School of Chinese Medicine, AIDS Institute, Department of Microbiology, School of Clinical Medicine and State Key Laboratory for Emerging Infectious Diseases, the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) have discovered a natural product SSP derived from a Chinese herb Spatholobus Suberectus Dunnthat demonstrated broad antiviral activities against SARS-CoV-1, SARS-CoV-2, influenza, and HIV-1 as an entry blocker.

27 Sep 2022

Specific N-glycans regulate the development and functional maturation of SARS-CoV-2 spike protein

If you're an avid reader of science news, you've probably heard of viral proteins such as the COVID-19 spike protein.

27 Sep 2022

The antibody response against SARS-CoV-2 in patients pre- and post-infusion with commercial intravenous immunoglobulin products

Researchers comparatively evaluated antibody responses against SARS-CoV-2 among immunodeficient individuals pre- and post-intravenous immunoglobulin product infusions.

27 Sep 2022

Study finds remdesivir-resistant version of COVID-19 in renal transplant recipients

Recent studies have shown that patients with weakened immune systems—which enables the virus that causes COVID-19 to remain longer in the body, copy itself, and continually change—may enable the development of new, slightly different versions of the virus (variants).

26 Sep 2022

Study demonstrates how pan-sarbecovirus ORF7a protein plays a role in evading host immunity

In a new study, researchers demonstrated how sarbecovirus family down-regulates major histocompatibility complex-I (MHC-I) surface expression to evade cellular immunity.

26 Sep 2022

Is covid ‘under control’ in the US? Experts say yes

President Joe Biden caused a stir in a “60 Minutes” interview on Sept. 18 when he declared that the covid-19 pandemic is over.

26 Sep 2022

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

In a recent study posted to the medRxiv* preprint server, researchers in the United States described the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), tested in PREVENT-19 — a phase 3, randomized, placebo-controlled, observer-blinded trial among 12- to 17-year-old adolescents in the United States (U.S).

25 Sep 2022

How smallpox and monkeypox viruses affect the nervous system

A recent study provides an overview of existing literature on the complications of infection with both smallpox and monkeypox virus.

25 Sep 2022

DNA nets effectively target the spike protein and detect COVID-19 virus at very low levels

Tiny nets woven from DNA strands can ensnare the spike protein of the virus that causes COVID-19, lighting up the virus for a fast-yet-sensitive diagnostic test – and also impeding the virus from infecting cells, opening a new possible route to antiviral treatment, according to a new study.

23 Sep 2022

HIV News and Research

Eligibility criteria lack clarity, justification for excluding people with disabilities from clinical trials

French study reports growing evidence of sexual activity-linked transmission of monkeypox

Obscure family of viruses already endemic in African monkeys "poised for spillover" to humans

Gut microbiome could contribute to a person's risk for HIV infection, research suggests

Effectiveness of anti-SARS-CoV-2 immunoadhesin against omicron and other emerging variants

Gut microbiome likely to contribute to HIV infection

Duration of infectiousness, predictors of ongoing individual infectiousness, and diagnostic tests for acute SARS-CoV-2 infection

Natural product SSP derived from a Chinese herb may have broad antiviral activities against respiratory viral infections

Specific N-glycans regulate the development and functional maturation of SARS-CoV-2 spike protein

The antibody response against SARS-CoV-2 in patients pre- and post-infusion with commercial intravenous immunoglobulin products

Study finds remdesivir-resistant version of COVID-19 in renal transplant recipients

Study demonstrates how pan-sarbecovirus ORF7a protein plays a role in evading host immunity

Is covid ‘under control’ in the US? Experts say yes

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescents

How smallpox and monkeypox viruses affect the nervous system

DNA nets effectively target the spike protein and detect COVID-19 virus at very low levels

Researchers secure $4.2 million NIH grant for improving PrEP access and use in the Bronx

Synthetic mucin gels against HIV-1 and HSV-2 transmission

Texas, battling teen pregnancy, recasts sex education standards

Monkeypox infection in a smallpox-vaccinated patient

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News